Merck has updated its discount and rebate program for 2023. APCI members will receive a percentage off discount on Merck vaccines and will have an opportunity to gain a rebate each quarter and cumulatively at the end of the year for aggregated vaccine sales of Gardasil 9, Pneumovax 23, and Vaxneuvance.
For example, a member can earn up to a 2 percent rebate each quarter if APCI reaches a target number of doses purchased for each quarter. Also, at the end of the year, members will receive an additional 1 percent rebate if total yearly purchase targets are achieved.
For details and more information, please visit the Professional and Clinical Affairs Resources page where you will find the link to the Merck-APCI 2023 Vaccine Agreement.